13 research outputs found

    The interplay between posture control and memory for spatial locations

    No full text
    Three experiments examined interactions between posture control in upright stance and a concurrent location memory task. Healthy young participants stood upright and memorized the locations of dots presented on a computer screen. In the retrieval phase, they indicated whether arrows presented on the screen would pass through any of the memorized locations. Postural sway variability was measured either during the retention period or during retrieval. Relative to not performing the memory task, postural sway variability increased in the retention period when the eyes were closed, but remained unaffected when the eyes were open. During retrieval, postural sway variability was reduced relative to the no-memory-task condition. Results were interpreted in terms of dual-task costs associated with maintaining multiple frames of reference

    Treating inborn errors of liver metabolism with stem cells: current clinical development

    Get PDF
    Abstract Advanced therapies including stem cells are currently a major biotechnological development. Adult liver stem cells can differentiate into hepatocyte like cells and be infused in the recipient’s liver to bring a missing metabolic function. These cells can be produced in large quantities in vitro. Allogeneic stem cells are required to treat genetic diseases, and this approach allows to use one single source of tissue to treat different diseases and many recipients. Mesenchymal stem cells can in addition play an immunomodulatory and anti-inflammatory role and possibly prevent the accumulation of fibrous tissue in the liver. From a regulatory point of view, stem cells are considered as medicinal products, and must undergo a pharmaceutical development that goes beyond the research and proof-of-concept phases. Here, we review the track followed from the first hepatocyte transplantation in 2000 to the next generation product issued from stem cell technology, and the start of EMA approved clinical trials to evaluate the safety and potency of liver stem cells for the treatment of inborn errors of the liver metabolism
    corecore